Immune to Cancer: The CRI Blog
-
FDA Approves First-In-Class CAR T Cell Immunotherapy for Leukemia
Children and young adults with relapsed/refractory acute lymphoblastic leukemia (ALL) can now receive the CD19-targeting CAR T…
-
Dennis B’s Immunotherapy Story
Leukemia The T cell experience was a walk through the park. It was a piece of cake… -
Milton W
Leukemia | Diagnosed 2013 They told me that my T cells were actually the best T cells they’ve… -
Karen Koehler’s Immunotherapy Story
Leukemia | Diagnosed 2011 It was brutal, but I was prepared…I bounced back very quickly. Karen’s Story When… -
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers
Combination checkpoints, improved CAR T cells show promise.
-
Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers
The era of powerful, personalized medicine draws near.
-
FDA Approves New Immunotherapy for Leukemia
Amgen’s Blincyto was approved by the FDA, making it the first approved bispecific T cell engaging (BiTE)…
-
CAR T Cell Therapy Surges Forward
Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…